Zentiva ks

Prague, Aug. 1, 2023 /PRNewswire/ -- Zentiva is a leading manufacturer and supplier of high-quality and affordable medicines to more than 100 million people in Europe and beyond. With sustainability embedded into its business strategy, the company fulfilled its 2022 sustainability goals and implemented actions in 3 pillars: People, Partners and Planet. Continue Reading Zentiva publishes 2022 Sustainability Report Steffen Saltofte, CEO Zentiva: "Zentiva continues to make a significant contribution to public health in Europe. We are aware of our responsibility towards people, our partners and our planet. ESG (Environmental, Social, Governance) is helping us to navigate and fulfill our ambitions. Encouraging progress has been made in 2022 thanks to the engagement of our people and the cooperation and constructive dialogue with our partners and stakeholders." PEOPLE: We continued to strengthen the Diversity, Equity and Inclusion approach and signed the Diversity Charter in the Czech Republic joining Romania and Slovakia as members in their country as well. At the end of 2022, Zentiva is role modeling Diversity with a healthy gender balance across the organization, same time going beyond the gender topic to fuel our creativity and innovation by bringing teams together with different cultural, national and educational background, different life experience or abilities. With our #WeHelpOthers program our team engaged in 100 volunteering activities and community support projects. PARTNERS: Zentiva joined the UN Global Compact on human rights, labour, environment & anti-corruption. On its way forward, the 10 principles and the 17 Sustainability Development Goals were embedded. It was a year of strengthening our governance, starting from an updated Risk & Materiality Analysis, better best practice sharing and collaboration between different teams. This helped to further move on with the responsible sourcing programme, where we reviewed Top 80% of suppliers and actively discussing our common activities towards a sustainable future. PLANET: We translated our climate strategy into actions and delivered significant improvements in carbon reduction, energy and water efficiency and more efficient waste management. We continued as well our reforestation programme by planting another 100.000 trees. Zentiva's European Manufacturing Sites are sourced by 100 % renewable energy and we further invest to maximize the usage of solar panels in all our sites. We continue our carbon neutral roadmap that is targeting neutrality for scope 1 and scope 2 emissions by 2030. Ines Windisch, Head of HR, Communication & Sustainability: "It is for a reason that the "e" in Zentiva is green. We are looking back at a history of more than 500 years where Zentiva served people and communities with better healthcare. We want to ensure that for future generations, so that they can enjoy life as much as we do. And we know we have to act already today for a sustainable tomorrow." Zentiva's 2022 Sustainability Report discloses the non-financial topics referencing GRI standards and presents first time a verified carbon footprint analysis as well for Scope 3 emissions. The company presents an ambitious outlook for 2023, showing full commitment to further progress in all areas of ESG. Discover Zentiva's Sustainability Strategy and Goals and the actions implemented here. About Zentiva Zentiva is a producer of high-quality affordable medicines serving people in Europe and beyond. With a dedicated team of more than 4,800 people and a network of production sites - including flagship sites in Prague, Bucharest, and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people's daily healthcare needs. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on. Follow us on LinkedIn. Photo - Logo - SOURCE Zentiva

Jim Mullen is lending his years of biotech CEO experience — from Biogen, Patheon and Editas — to the private equity firm Advent International. Advent managing partner John Maldonado said Mullen will help his team expand their reach to pharmaceutical and pharma services companies “across contract manufacturing, commercialization, and research.” “Jim’s work at Editas and Thermo Fisher have put him at the forefront of the cell and gene therapy revolution,” Carmine Petrone, managing director at Advent, added in a statement. “We are excited to partner with Jim as we continue to look for transformative companies that are enabling the development, manufacture and commercialization of these advanced therapies.” As an operating partner , Mullen joins more than 125 industry executives as independent advisors to Advent and its portfolio companies. Mullen was perhaps best known as the former CEO of Biogen, who presided over its merger with Idec in 2003 and the growth of its multiple sclerosis franchise — but was ultimately pushed out by activist investors. After leaving Biogen, he took up the CEO role at contract development and manufacturing organization Patheon, which was sold to Thermo Fisher for $7.2 billion in 2017. He also briefly served as CEO of gene editing pioneer Editas, where he remains chairman . In May, Advent closed its 10th fund with $25 billion raised. Other than healthcare, the firm also invests in business & financial services; industrial; retail, consumer & leisure; and technology. It counts close to 50 healthcare investments since 1990, betting on a range of companies around the world. Its pharma portfolio features CRO Syneos Health, generic makers Zentiva (Czech Republic) and Grupo Farmaceutico Somar (Mexico), India’s Bharat Serums and Vaccines, and Chinese capsule developer GS Capsule. In recent years, though, Advent has made attempts to play a more direct role in drug development, including an ill-fated $8 billion deal to take rare disease player Sobi private and rumored talks with GSK about its consumer health spinout.

The company further strengthens its contribution to a healthier planet as part of their Sustainability strategy PRAGUE, March 21, 2023 /PRNewswire/ -- Zentiva today celebrates the International Day of Forests by committing to plant 1 million trees by 2030. Being a producer of high-quality and affordable medicines, Zentiva is generating carbon emissions and is aware of its impact on the environment. That is why the company committed to a strong sustainability program as part of its business strategy. Nick Haggar, CEO of Zentiva: "At Zentiva, we ensure medicines supply and more than 100 million people in Europe and beyond trust in our products. We have defined a comprehensive Sustainability Strategy and we have formalized our commitment to become carbon neutral for scope 1 and scope 2 by 2030. On top, we are further investing in programs to improve our efficiency in energy, water and waste management. I am proud that actions are real and not just paper commitments." Zentiva's Sustainability journey started back in 2019 by planting the first trees in Romania. Since then, the company has already planted more than 250.000 trees as part of its reforestation and offsetting program. The formalization of the 1-Million-Trees commitment is another milestone for the team. Ines Windisch, Head of HR, Communications & Sustainability: "Everyone in our company is involved in the Sustainability agenda as we believe that every small step and every small contribution counts. We are focusing our efforts not only on efficiency programs but as well on Biodiversity, supporting nature to recover and restore local ecosystems. There is just one Planet, and we want that future generations will enjoy their lives on Earth as much as we do." Zentiva has continued to significantly reduce its CO2 emissions during 2022 following on from a 16% reduction in 2021. It is important that all companies work to reduce their environmental impact and the Zentiva team is proud of the progress it is making. While the company's sustainability strategy is framed around 3 pillars: People, Partners and Planet, Zentiva will achieve the goal of carbon neutrality by focusing on reducing carbon emissions, sourcing from renewable energy, and increasing efficiency in energy, water and waste management. Click here to read more information about Sustainability at Zentiva. Logo - SOURCE Zentiva